# Business Of Biotech Page: https://stenobird.com/podcast/business-of-biotech-123501 Text version: https://stenobird.com/podcast/business-of-biotech-123501.md RSS feed: https://rss.buzzsprout.com/1011661.rss Official site: https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast Author: Ben Comer Episodes: 310 ## Resource The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect. ## Machine-readable JSON: https://stenobird.com/v1/public/podcasts/business-of-biotech-123501 Markdown: https://stenobird.com/podcast/business-of-biotech-123501.md ## Episodes - [The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry](https://stenobird.com/podcast/business-of-biotech-123501/the-editors-roundtable-a-midyear-look-at-the-2026-life-sciences-industry) — 2026-06-08T10:00:00+00:00 - [Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.](https://stenobird.com/podcast/business-of-biotech-123501/derisking-cns-drug-development-with-tortugas-neuroscience-s-jeff-jonas-m-d) — 2026-06-01T10:00:00+00:00 - [Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane](https://stenobird.com/podcast/business-of-biotech-123501/rare-disease-drug-commercialization-with-zevra-therapeutics-neil-mcfarlane) — 2026-05-25T10:00:00+00:00 - [Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.](https://stenobird.com/podcast/business-of-biotech-123501/scaling-manufacturing-for-personalized-cell-therapies-with-cellino-s-marinna-madrid-ph-d) — 2026-05-18T10:00:00+00:00 - [Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.](https://stenobird.com/podcast/business-of-biotech-123501/building-a-new-antibody-discovery-platform-with-infinimmune-s-wyatt-mcdonnell-ph-d) — 2026-05-11T10:00:00+00:00 - [From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.](https://stenobird.com/podcast/business-of-biotech-123501/from-partnered-aso-therapies-to-a-wholly-owned-pipeline-with-ionis-s-brett-monia-ph-d) — 2026-05-04T10:00:00+00:00 - [Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary](https://stenobird.com/podcast/business-of-biotech-123501/implementing-a-new-ceo-strategy-with-nervgen-s-adam-rogers-m-d-and-rich-macary) — 2026-04-27T10:00:00+00:00 - [The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw](https://stenobird.com/podcast/business-of-biotech-123501/the-impact-of-fda-risk-on-biotech-rewards-with-cfo-and-board-director-allan-shaw) — 2026-04-20T10:00:00+00:00 - [Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.](https://stenobird.com/podcast/business-of-biotech-123501/biosimilars-and-complex-medicines-for-all-with-rna-therapeutics-sarfaraz-niazi-ph-d) — 2026-04-13T10:00:00+00:00 - [Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor](https://stenobird.com/podcast/business-of-biotech-123501/radiotherapeutics-for-neuroendocrine-tumors-with-perspective-therapeutics-thijs-spoor) — 2026-04-06T10:00:00+00:00 - [Investing In Early-Stage Oncology With Yosemite's Dan McHugh](https://stenobird.com/podcast/business-of-biotech-123501/investing-in-early-stage-oncology-with-yosemite-s-dan-mchugh) — 2026-03-30T10:00:00+00:00 - [Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash](https://stenobird.com/podcast/business-of-biotech-123501/commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash) — 2026-03-23T10:00:00+00:00 - [Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.](https://stenobird.com/podcast/business-of-biotech-123501/radiotherapeutics-for-cns-cancers-with-plus-therapeutics-marc-hedrick-m-d) — 2026-03-16T10:00:00+00:00 - [Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.](https://stenobird.com/podcast/business-of-biotech-123501/developing-novel-cancer-drugs-on-a-budget-with-iterion-therapeutics-rahul-aras-ph-d) — 2026-03-09T10:00:00+00:00 - [Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.](https://stenobird.com/podcast/business-of-biotech-123501/making-biologics-orally-available-with-vivtex-s-thomas-von-erlach-ph-d) — 2026-03-02T11:00:00+00:00 - [An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.](https://stenobird.com/podcast/business-of-biotech-123501/an-anthropological-lens-on-leadership-in-life-sciences-with-bunka-s-monika-sumra-ph-d) — 2026-02-23T11:00:00+00:00 - [Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer](https://stenobird.com/podcast/business-of-biotech-123501/company-turnarounds-and-ai-for-infectious-diseases-with-seek-labs-jared-bauer) — 2026-02-16T11:00:00+00:00 - [Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie](https://stenobird.com/podcast/business-of-biotech-123501/bringing-curative-cell-therapies-to-market-with-kite-pharma-s-cindy-perettie) — 2026-02-09T11:00:00+00:00 - [BoB@JPM: Brian Hilberdink, Boehringer Ingelheim](https://stenobird.com/podcast/business-of-biotech-123501/bob-jpm-brian-hilberdink-boehringer-ingelheim) — 2026-02-02T11:00:00+00:00 - [BoB@JPM: Ron Cooper, enGene](https://stenobird.com/podcast/business-of-biotech-123501/bob-jpm-ron-cooper-engene) — 2026-01-26T11:00:00+00:00 - [BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics](https://stenobird.com/podcast/business-of-biotech-123501/bob-jpm-marc-salzberg-m-d-airway-therapeutics) — 2026-01-19T11:00:00+00:00 - [A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith](https://stenobird.com/podcast/business-of-biotech-123501/a-royalty-model-for-value-creation-with-zymeworks-kenneth-galbraith) — 2026-01-12T11:00:00+00:00 - [Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead](https://stenobird.com/podcast/business-of-biotech-123501/life-science-connect-editors-roundtable-wrapping-up-2025-and-looking-ahead) — 2026-01-05T11:00:00+00:00 - [Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos](https://stenobird.com/podcast/business-of-biotech-123501/building-cell-therapy-companies-with-kenai-therapeutics-nick-manusos) — 2025-12-29T11:00:00+00:00 - [Modernizing Clinical Trial Operations With Merck's Jennifer Sheller](https://stenobird.com/podcast/business-of-biotech-123501/modernizing-clinical-trial-operations-with-merck-s-jennifer-sheller) — 2025-12-22T11:00:00+00:00 - [Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.](https://stenobird.com/podcast/business-of-biotech-123501/transforming-chronic-kidney-disease-with-prokidney-s-bruce-culleton-m-d) — 2025-12-15T11:00:00+00:00 - [Engineering B Cells With Immusoft's Sean Ainsworth](https://stenobird.com/podcast/business-of-biotech-123501/engineering-b-cells-with-immusoft-s-sean-ainsworth) — 2025-12-08T11:00:00+00:00 - [Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt](https://stenobird.com/podcast/business-of-biotech-123501/building-a-cancer-pipeline-in-a-molecule-with-actuate-therapeutics-dan-schmitt) — 2025-12-01T11:00:00+00:00 - [Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.](https://stenobird.com/podcast/business-of-biotech-123501/biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d) — 2025-11-24T11:00:00+00:00 ## Actions Episode pages expose an explicit `request_transcript` action. A page view does not automatically enqueue transcription.